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AORTIC STENOSIS (AS) induces pressure overload of the left ventricle (LV). This results in pathological myocardial remodeling, consisting of hypertrophy of cardiomyocytes and quantitative and qualitative changes in the extracellular matrix (ECM). Unless patients with AS undergo aortic valve replacement, the pathological remodeling may ultimately lead to development of heart failure (29) . Because available therapies for heart failure do not correct the underlying pathology, there is a need to find new strategies that target mechanisms responsible for pathological remodeling of the myocardium (12) . To eventually be able to medically induce reverse myocardial remodeling, a first step could be to increase the knowledge of the participants and regulators of the reverse remodeling process, with normalization of both myocardial hypertrophy and the alterations in ECM, such as usually seen in patients with AS following aortic valve replacement (21) .
Dynamic alterations in the ECM are essential both in cardiac remodeling and reverse remodeling. ECM consists mainly of collagens and proteoglycans. The small, leucine-rich proteoglycans (SLRPs) are a family of ECM proteins composed of a protein core with leucine-rich repeat motifs, N-linked oligosaccharides, and at least one glycosaminoglycan (GAG) side chain. These side chains can be chondroitin sulfate (CS), dermatan sulfate (DS), or keratan sulfate (KS) (14) . A complex biosynthetic machinery is required to create the GAG chains of CS/DS proteoglycans (i.e., decorin) and KS proteoglycans (i.e., lumican) (11, 14 -16, 20) . Several enzymes generate the CS/DS polysaccharide of decorin, chondroitin polymerizing factor (CHPF), CS synthase (CHSY)-1, -3, and CS N-acetylgalactosaminyltransferase (CSGALNACT)-1, 2, and DS chain is converted from CS chain by DS epimerase (30) . Lumican has two or three keratan sulfate (KS) side chains. Presently, KS chain polymerization is found to be mediated by ␤1, 4-galactosyltransferase (B4GALT)-1, -2, -3, and -4 and by ␤1, 3-Nacetylglucosaminyltransferase (B3GNT)-1, -2, and -7 (11) .
SLRPs bind to various types of collagen-fibril components, thereby regulating the kinetics, assembly, spatial organization, and stabilization of fibrils (19) . SLRPs may also influence tissue fibrosis through interaction with transforming growth factor (TGF)-␤ (25, 27) . More recently, SLRPs have also been found to modulate inflammatory responses at least partly through toll-like receptors (31) .
SLRPs have been shown to play a role in fibrogenesis and inflammation, both known to occur in myocardial remodeling and reverse remodeling. Thus the aim of this study was to examine the protein levels of the SLRPs decorin and lumican as well as several of their GAG-synthesizing enzymes in cardiac remodeling and reverse remodeling. For this purpose, we used a well-characterized banding-debanding model in the mouse, simulating AS and aortic valve replacement (5, 7). We have put special emphasis on decorin and lumican since a role for these SLRPs in cardiac biology has been suggested (35, 36) . Moreover, C-X-C motif ligand-13 (CXCL13) and -16 (CXCL16), CX3CL1/ fractalkine, and CCL5/RANTES have been shown to induce mRNA and protein levels of decorin and lumican (35, 36) . We stimulated cardiac fibroblasts with these chemokines to see if they also can modulate specific CS/DS and KS chain-synthesizing enzymes. Knowledge about alterations in the expression of SLRPs after debanding (DB), as well as possible regulatory mechanisms, could give valuable information in the important process of reverse myocardial remodeling.
MATERIALS AND METHODS
Experimental mouse model. All animal experiments were approved by The Norwegian Animal Research Committee, which conforms to the Guide for the Care and Use of Laboratory Animals published by US National Institutes of Health. The experimental mouse model has been previously described in detail (5, 7) . Briefly, we performed a banding operation of the ascending aorta (AB) on 7-wk-old C57Bl/6 male mice. After 4 wk of banding, mice were subjected to a DB operation and followed for 3 or 14 days.
Echocardiography. We performed echocardiography using a VIVID 7 system (GE Vingmed Ultrasound, Horten, Norway) and an i13L 13-MHz linear array transducer designed for small-rodent examinations, as previously described (5-7). Anesthesia was inducted with isoflurane in a chamber, followed by breathing 2% isoflurane spontaneously on a mask. Images were recorded by a cardiologist (IS). Mice were examined in the supine position on a heated table. We measured the pressure gradient from AB by measuring maximum flow velocity across the stenosis by pulsed-wave Doppler sonography. The cutoff value was set to 3 m/s, since mice with lower pressure gradient often develop inadequate hypertrophy. Four weeks after AB and 3 or 14 days after DB, standardized echocardiographic recordings for analysis of cardiac dimensions was performed.
RNA isolation. We extracted total RNA from LV tissue samples and neonatal rat fibroblasts using RNeasy fibrous tissue miniprotocol. (RNeasy Mini Kat, cat. no. 74104, Qiagen). Concentrations were measured with Nano Drop (ND-1000 Saveen Werner, Malmö, Sweden). RNA quality was measured by RNA integrity number (RIN) on Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Mean RIN was 8.15 Ϯ 0.13. Reverse transcription was performed using iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA).
Quantitative real-time PCR (RT-PCR).
Real-time polymerase chain reaction was carried out in a 7900 HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). Predesigned TaqMan assays (Applied Biosystems) were used to determine gene atrial natriuretic peptide (ANP) (Mm01255747_g1), cardiac beta-myosin heavy chain (␤-MHC) (Mm00600555_m1), skeletal muscle actin-␣1 (ACTA1) (Mm00808218_g1), fibroblast activation protein (FAP) (Mm01329177_ m1), smooth muscle cell-specific protein (SM22) (Mm00441660_m1), TGF-␤1 (Mm03024053_m1), CXCL16 (Mm00469712_m1), CHPF (Mm01262239_g1 and Rn01400270_m1), CHSY-1 (Mm01319178_m1 and Rn01478125_m1), CHSY-3 (Mm01545329_m1), CSGALNACT-1 (Mm00555164_m1), CSGALNACT-2 (Mm00513340_m1 and Rn01459423_g1), DS epimerase (Mm00552923_m1 and Rn02109126_ s1), B4GALT-1 (Mm00480752_m1), B4GALT-2 (Mm00479556_m1 and Rn01417399_m1), B4GALT-3 (Mm00480426_m1), B4GALT-4 (Mm00480087_m1), B3GNT-1 (Mm00723578_m1), B3GNT-2 (Mm00479497_s1 and Rn02112835_s1), and B3GNT-7 (Mm00507533_ m1 and Rn02534341_s1). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Mm99999915_g1 and Rn01775763_g1) was used for normalization. The data were analyzed using Sequence Detection Software 2.3 (Applied Biosystems).
Western blot. The extracted and denatured cardiac tissue protein samples were separated through a 4 -15% Criterion Precast Gel (Bio-Rad) and transferred to PVDF membranes (GE Health Care Bio-Sciences, Uppsala, Sweden) by electrophoretic blotting. Membranes were blocked in TBS-Tween-20 (0.1%) containing 5% BSA or 5% skim milk for 1 h at room temperature, and probed with primary antibodies for 1:500 lumican (AF2745, R&D Systems Europe, Abingdon, Oxon, UK) in 5% BSA, 1:500 decorin (AF1060, R&D Systems Europe) in 5% BSA, 1:500 CHPF (HPA035123, Sigma-Aldrich) in 5% BSA, 1:200 CHSY-1 (SC-50545, Santa Cruz Biotechnology, Santa Cruz, CA) in 5% BSA, 1:200 CSGALNACT-2 (SC-139353, Santa Cruz Biotechnology) in 5% BSA, 1:200 DS epimerase (SC-169252, Santa Cruz Biotechnology) in 5% skim milk, 1:500 B4GALT-2 (ab102978, Abcam, Cambridge, UK) in 5% BSA, 1:200 B3GNT-2 (SC-160948, Santa Cruz Biotechnology) in 5% BSA, 1:200 B3GNT-7 (SC-167010, Santa Cruz Biotechnology) in 5% skim milk, and 1:300 collagen type I (#234167 Millipore, Billerica, MA) in 5% skim milk at 4°C overnight. For the latter the 5% skim milk was diluted in PBS-T. Membranes were then washed with TBS-Tween-20 and incubated with species-specific horseradish peroxidase-conjugated secondary antibody in BSA 5%. The proteins were visualized by enhanced chemiluminescence according to the manufacturer's guidelines (Amersham ECL Plus, GE Healthcare Bio-Sciences). Relative intensities of protein bands were quantified using "ImageQuant-TL" Software (Amersham Biosciences, GE Healthcare Bio-Sciences AB). Membranes were reprobed with vinculin as protein loading control. For the analysis of decorin protein core, 40 g protein was subjected to enzymatic treatment with both chondroitinase ABC (Sigma-Aldrich, St. Louis, MO) and PNGaseF in a protein deglycosylation mix [PNGase F, endo-␣-N-acetylgalactosaminidase, neuraminidase, ␤1-4 galactosidase and ␤-N-acetylglucosaminidase (P6039, New England BioLabs, Beverly, MA)]. Eight microlite chondroitinase ABC was added at 37°C overnight to remove CS or DS side chains from the protein cores of decorin. N-linked oligosaccharides attached to the decorin core protein were enzymatically released using 4 l of the deglycosylation enzyme mix containing PNGase F according to the manufacturer's instruction (P6039S, New England BioLabs). Forty micrograms protein was digested with 8 l keratanase II (Seikagaku Biobusiness, Tokyo, Japan) at 37°C overnight, to remove KS side chains from the protein core of lumican. This sample was further digested with 4 l of the deglycosylation enzyme mix containing PNGase F. The reaction was terminated by boiling the samples for 10 min at 100°C.
Isolation and stimulation of neonatal rat cardiac fibroblasts. Primary neonatal fibroblasts were isolated from 1-to 3-day-old Wistar rats (Taconic, Skensved, Denmark) as previously described (4). The cells were treated for 24 h with or without chemokines (200 ng/ml): CX3CL1/fractalkine, CCL5/RANTES, chemokine (C-X-C motif) ligand 13 (CXCL13), and 16 (CXCL16) and TGF-␤ (all from R&D Systems, Minneapolis, MN).
Statistical analyses. Data are presented as means Ϯ SE. Differences between two groups were analyzed using Student's t-test or Mann-Whitney Rank Sum Test when appropriate. To compare between the intervention groups we used one-way ANOVA. HolmSidak method or Dunn's method was used to correct for post hoc multiple testing. For the correlation analyses, data were pooled from all time points (sAB, AB, sDB3, DB3, sDB14, and DB14) unless other is specified. When appropriate, data were transformed by natural logarithm. As the level of statistical significance, we used a two-tailed significance level of ␣ ϭ 0.05. For the analyses, Sigma plot 11.0 (Systat Software, San Jose, CA) was used.
RESULTS

Myocardial function in remodeling and reverse remodeling of the LV.
Maximum flow velocity across the stenosis in AB mice was 4.3 Ϯ 0.3 m/s. Moreover, LV weight was 70% increased in AB mice compared with sham, and 14 days after DB LV weight was reduced toward sham-operated levels ( Table 1) . Lung weight was increased by 85% in AB mice, with a gradual decline after DB (Table 1) . Echocardiographic measurements revealed increased left atrial diameter after AB, reflecting increased LV preload, as well as increased relative wall thickness reflecting concentric remodeling (Table 1) . Relative wall thickness was already decreased 3 days after DB compared with AB, whereas left atrial diameter was decreased 14 days after DB. As expected, the fetal genes associated with hypertrophy of cardiomyocytes (i.e., ACTA1 and ␤-MHC) and genes reflecting enhanced myocardial wall stress (i.e., ANP) were increased after AB and declined toward sham-operated levels 14 days after DB (Table 1) . TGF-␤ has previously been shown to be increased and play a role in myocardial fibrosis in AS (10, 34) . Interestingly, TGF-␤ mRNA was increased after AB and decreased to sham-operated levels following DB (Table 1) . Moreover, Western blotting revealed increased collagen type I protein after AB, no longer significantly increased 3 and 14 days after DB (Table 1) . Interestingly, fibroblast activation protein (FAP), a marker of ECM remodeling and fibrosis (17) , was increased after AB and declined to shamoperated levels 14 days after DB (Table 1 ). This was supported by an increase in smooth muscle cell-specific protein (SM22) associated with activation of cardiac fibroblasts (13) following AB with a decline to sham-operated levels 14 days after DB (Table 1) . Finally, gene expression of the inflammatory chemo- 
Left ventricular weight and lung weight are normalized to right tibia length. Echocardiography from sham-operated DB animals (sDB) did not differ from sham-operated AB (sAB) data and are not presented. For the RT-PCR and protein data, all values are relative to sham-operated controls to AB (sAB) and are presented as means Ϯ SE; AB, aortic banding; DB, debanding; s, sham; DB3 and DB14, 3 and 14 days after debanding; NA, not available; *P Ͻ 0.05 vs. respective sham-operated level. †P Ͻ 0.05 vs. AB. Fig. 1 . Protein levels of decorin in the left ventricle (LV) of mice after aortic banding (AB; n ϭ 8), and 3 and 14 days after debanding (DB3 and DB14; n ϭ 8) compared with respective sham-operated mice (sAB, sDB3, sDB14) (n ϭ 5). All values are relative to sham-operated levels of AB (sAB) (n ϭ 7). Data are shown as representative Western blots and means Ϯ SE (column bar graphs). Western blots show samples without (A and B) and with (C) chondroitinase ABC and PNGase F treatment. The column bar graphs show relative protein level of glycosylated (glyc) decorin at 60 -100 kDa (A) as well as the ϳ43 kDa band (B), representing core protein of decorin with one or more N-oligosaccharides attached. C: the relative protein level of the core protein at ϳ37 kDa after enzymatic digestion. To be able to compare the 3 separate Western blots, sAB was present on all blots (n ϭ 4 -7) and all the protein levels are relative to sAB and normalized to vinculin. *P Ͻ 0.05 vs. respective sham-operated level; #P Ͻ 0.05 vs. AB. kine CXCL16 was increased after AB and no longer significantly increased after DB, suggesting a reversal of both the inflammatory and the fibrotic response due to pressure overload.
Protein levels of decorin following remodeling and reverse remodeling of the LV. As depicted in Fig. 1 , Western blots of decorin from the LV of sham-operated mice, as well as AB mice and mice 3 and 14 days after DB, revealed several bands between 60 and 100 kDa, with the highest molecular weight in the AB mice. These bands represent glycosylated decorin with a CS/DS GAG chain of different length (Fig. 1A) . Quantification of the total intensities of the 60-to 100-kDa bands revealed a 2.5-fold increase in the glycosylated form of decorin after AB compared with sham-operated mice, with a gradual decrease after DB reaching statistical significance compared with AB after 14 days (Fig. 1A) . In contrast, the band at ϳ43 kDa, representing core protein of decorin with one or more N-oligosaccharides attached (3, 8, 9 ), was not regulated between the different groups (Fig. 1B) . As shown in Fig. 1C , the CS/DS glycosylated decorin was digested after enzymatic treatment by chondroitinase ABC (to remove the CS/DS GAG chain) and PNGase F (to remove N-linked oligosaccharides), leaving decorin as a core protein at 37 kDa, which was increased by 1.7-fold after AB, and still remained increased after DB. Following AB, glycosylated decorin correlated positively with LV weight (R ϭ 0.75, P ϭ 0.02) and lung weight (R ϭ 0.59, P ϭ 0.02). Three days after DB, glycosylated decorin still correlated positively with lung weight (R ϭ 0.63, P ϭ 0.02), but 14 days after DB we found no significant correlations between glycosylated decorin and LV weight or lung weight. Glycosylated decorin correlated positively with the genes associated with cardiomyocyte hypertrophy, ACTA1 and ␤-MHC (R ϭ 0.63 and R ϭ 0.78, P Ͻ 0.001), as well as ANP (R ϭ 0.65, P Ͻ 0.001), associated with myocardial wall stress. Moreover, glycosylated decorin correlated positively with protein levels of the collagen type I (R ϭ 0.42, P Ͻ 0.01), and genes associated with cardiac fibrosis and remodeling: TGF-␤ (R ϭ0.53, P Ͻ 0.001), FAP (R ϭ 0.39, P ϭ 0.02), and SM22 (R ϭ 0.51, P ϭ 0.002).
CS/DS GAG chain-synthesizing enzymes following remodeling and reverse remodeling of the LV. Our findings suggest a regulation of CS/DS glycosylated decorin in the LV, with an increase after AB that is reversed after relief of pressure overload. To examine the mechanism behind this regulation, we used LV samples from the same mice to measure mRNA expression of enzymes important for synthesis of the CS/DS GAG chain of decorin. As shown in Fig. 2 , mRNA levels of CHPF, CHSY-1 and -3 and CSGALNACT-2 were all increased following AB, but notably, only CHSY-1 and -3 decreased following DB. Also, DS epimerase, which converts CS to DS, was increased after AB, but with no decrease during DB (Fig. 2F) . Finally, CSGALNACT-1, also involved in the CS/DS synthesis, was not altered in the AB-DB groups (Fig.  2D) . Following AB, mRNA levels of CHPF, CHSY-3, CSGALNACT-2, and DS epimerase were positively correlated with LV weight (R ϭ 0.86, 0.62, 0.72, and 0.86, P Ͻ 0.05) and CHPF, CHSY-3, and DS epimerase with lung weight (R ϭ 0.87, 0.80 and 0.85, P Ͻ 0.001). As shown in Fig. 3 , immunoblotting revealed increased protein levels of the key enzymes CHPF isoform B (28), CHSY-1, and CSGALNACT-2 isoform 2, following AB. Interestingly, CHPF and CHSY-1 were significantly decreased 14 days after DB compared with AB. CSGALNACT-2 remained increased 14 days after DB (Fig.  3C) . Protein levels of CHPF, CHSY-1 and CSGALNACT-2 correlated positively with glycosylated decorin (R ϭ 0.71, 0.49, and 0.52, respectively, P Ͻ 0.001 for all). DS epimerase protein was not significantly altered following AB and DB (Fig. 3D) , indicating that the CS GAG chain is more important than DS in cardiac remodeling and reverse remodeling.
Protein levels of lumican following remodeling and reverse remodeling of the LV. Western blot analysis of lumican resulted in a distinct band at 50 kDa, only weakly expressed in the sham-operated animals, corresponding to lumican core protein with N-linked oligosaccharides (1) and the typical proteoglycan smear at 60 -90 kDa, characteristic of lumican with KS GAG chains (26) in the LV in all groups (Fig. 4A) . As shown in Fig. 4A , quantification of the 50-kDa band, representing N-glycosylated lumican core protein, revealed a sevenfold increase in the LV of AB mice compared with shamoperated mice, with a gradual decrease after DB reaching statistical significance compared with AB mice after 14 days. Quantification of the 60-to 90-kDa KS proteoglycan smear, representing lumican with KS chains, revealed no significant alterations after AB and DB (Fig. 4B) . As shown in Fig. 4C , after enzymatic treatment by keratanase II (to remove keratan sulfate) and PNGaseF (to remove N-linked oligosaccharides), a 37-kDa band, corresponding to the core protein was evident. Quantification of this core protein band at 37 kDa after enzymatic digestion revealed a 2.8-fold increase in the total protein level of lumican after AB, with no decrease following DB (Fig.  4C) . Lumican ϳ50 kDa was positively correlated with LV weight (R ϭ 0.62, P ϭ 0.01) and lung weight (R ϭ 0.70, P Ͻ 0.02) following AB. Three days after DB lumican remained positively correlated with LV weight (R ϭ 0.60, P ϭ 0.03) and lung weight (R ϭ 0.76, P ϭ 0.003), but as for glycosylated decorin, we found no significant association between lumican ϳ50 kDa and LV weight and lung weight 14 days after DB. These lack of correlations 14 days after DB may suggest a normalization of these processes after DB as a reflection of reverse remodeling. As for glycosylated decorin, N-glycosylated lumican at ϳ50 kDa correlated positively with gene expression of ACTA1 (R ϭ 0.72, P Ͻ 0.001), ␤-MHC (R ϭ 0.57, P Ͻ 0.001), ANP (R ϭ 0.72, P Ͻ 0.001), TGF-␤ (R ϭ 0.59, P Ͻ 0.001), FAP (R ϭ 0.36, P ϭ 0.04), SM22 (R ϭ 0.65, P Ͻ 0.001), and protein levels of collagen type I (R ϭ 0.33, P ϭ 0.04).
Gene expression of KS chain-synthesizing enzymes following remodeling and reverse remodeling of the LV. It seems that N-glycosylated lumican core protein is by far the most regulated form of lumican in cardiac remodeling, and not lumican with KS chains attached, and as seen in Fig. 5 , the mRNA expression of only two of six enzymes important for KS GAG chain synthesis were regulated after AB. Thus B3GNT-2 ( Fig.  5F ) and B3GNT-7 (Fig. 5G) were increased after AB, but only the latter decreased following DB. One enzyme, B4GALT-2, decreased after DB, but with no difference between AB and sham-operated mice (Fig. 5B) . Following AB, B3GNT-2 correlated positively with LV weight (R ϭ 0.57, P ϭ 0.04), whereas B4GALT-2 and B3GNT-7 correlated positively with lung weight, (R ϭ 0.74 and 0.91, P Ͻ 0.01). As seen in Fig. 6 , immunoblotting revealed no significant alterations on the protein level following AB and DB compared with respective sham-operated level of B4GALT-2, B3GNT-2, or B3GNT-7, although B3GNT-7 was decreased 14 days after DB compared with AB. Thus, although we found that mRNA expression of two of six enzymes important for KS GAG chain synthesis were regulated after AB (i.e., B3GNT-2 and B3GNT-7) with a decrease in the latter following DB, our new protein data suggest that there are few or no alterations in the KS GAG chain-synthesizing enzymes following AB and DB.
Regulation of the CS/DS and KS GAG chain-synthesizing enzymes in neonatal rat cardiac fibroblasts by chemokines.
We have previously shown that certain chemokines [i.e., CXCL13, CXCL16, CX3CL1, and CCL5 (only lumican)] increased the protein levels of decorin and lumican in cardiac fibroblasts (35, 36) . To examine if these chemokines could regulate the CS/DS and KS GAG chain(s) of decorin and lumican through modulation of the specific CS/DS and KS synthesizing enzymes, we stimulated rat cardiac fibroblasts with CXCL13, CXCL16, CX3CL1, and CCL5 and examined mRNA expression of the same CS/DS and KS chain-synthesizing enzymes that were regulated in the LV after AB and DB. TGF-␤ was included as a control as it is known to regulate CS/DS glycosylation (3). As shown in Fig. 7A, CXCL16 , but not CX3CL1, CCL5, and CXCL13, increase the expression of CHPF with no effects of the other CS/DS chain-synthesizing enzymes. TGF-␤ increased the expression of several CS/DS-synthesizing enzymes: CHSY-1, CHSY-3, and DS epimerase (Fig.  7, B, C, and D) . As shown in Fig. 7G, CXCL16 , but not the other chemokines, reduced the expression of B3GNT-2, one of the KS-synthesizing enzymes that revealed increased gene expression in the LV after AB. In contrast, none of the chemokines had any significant effect on B4GALT-2 and B3GNT-7 (Fig. 7, F and H) , the other two KS-synthesizing enzymes that were regulated at mRNA level during AB and DB.
DISCUSSION
The key results of the present work were 1) increased protein levels of glycosylated decorin in the LV of mice after AB, together with increased expression of several CS/DS GAG chain-synthesizing enzymes; 2) a gradual decrease in both the glycosylated protein levels of decorin and certain CS/DS GAG-synthesizing enzymes (i.e., CHPF and CHSY-1) in the LV after DB; 3) upregulation of one of these CS/DS enzymes, CHPF, in cardiac fibroblasts after CXCL16 stimulation; 4) increased protein levels of lumican core protein with N-linked oligosaccharides, in the LV of mice after AB, which were decreased after DB; and 5) positive correlations between glycosylated decorin and N-glycosylated lumican with genes associated with cardiomyocyte hypertrophy (i.e., ACTA1, ␤-MHC), wall stress (i.e., ANP), protein levels of collagen type I, and genes associated with cardiac fibrosis and remodeling (i.e., TGF-␤, FAP and SM22). These findings further link decorin and lumican to myocardial remodeling and reverse remodeling during AS and its surgical treatment, with a potential important role of the CS/DS GAG-synthesizing enzymes CHPF and CHSY-1.
A major finding in the present study was the marked increase in protein levels of glycosylated decorin after AB, followed by a gradual decrease after DB. Interestingly, the molecular size of glycosylated decorin after AB, due to CS/DS GAG chain elongation, was also reduced after DB. Thus both the elongation and the increased level of glycosylated decorin after AB were reversed after relief of pressure overload, suggesting important roles of these molecules in the pressure-overloaded heart. This was further supported by the positive correlations between glycosylated decorin and genes associated with cardiomyocyte hypertrophy and myocardial fibrosis as well as the positive correlations between glycosylated decorin and mRNA expressions of several of the GAG-synthesizing enzymes with LV weight and lung weight. Modulation of the size and structure of CS/DS GAG chains has been shown in healing skin and in granulation tissue (22) . It has been proposed that CS/DS controls the size of the interfibrillar space between collagen fibrils in the cornea and sclera of the eye as well as in postinflammatory healing skin (22, 32) . It is tempting to hypothesize that the elongated CS/DS GAG chain of decorin is important in the pressure-overloaded heart to regulate the organization and distance of collagen fibrils, a process that might be relevant for the remodeling of the myocardial ECM. The reversal of the elongated CS/DS GAG chain of decorin after relief of the pressure overload further supports such a notion. . C: column bar shows the relative protein level of the core protein at ϳ37 kDa after enzymatic digestion. To be able to compare the three separate Western blots, sAB was present on all blots (n ϭ 4 -7) and all the protein levels are relative to sAB and normalized to vinculin. §Increased contrast. *P Ͻ 0.05 vs. respective sham-operated level. #P Ͻ 0.05 vs. AB.
Although it is known that glycosylation of decorin and the elongation of the CS/DS GAG chain are regulated by specific enzymes, no previous study has reported regulation of those enzymes in the pressure-overloaded heart. We found increased expression of several enzymes known to synthesize CS/DS GAG chains. CHPF, CHSY-1 and -3, as well as CSGALNACT2 were upregulated in the pressure-overloaded LV, indicating increased glycosylation and elongation of the CS/DS GAG chain of decorin (33) . This was further supported by increased protein levels of the enzymes CHPF, CHSY-1, and CSGALNACT2 following AB. The CS/DS GAG chain may also be modified by epimerization, which changes the sugars from GlcA to IdoA by DS epimerase (30) , but although we found that DS epimerase mRNA was upregulated in the LV after AB, protein levels were not significantly altered. Thus the transcript levels of CS/DS enzymes correlate well with increased glycosylation of decorin and an elongation of the CS/DS GAG chain in the pressure-overloaded heart. Interestingly, 14 days after relief of the pressure overload due to DB, only CHPF and CHSY-1 showed the same reduction in the protein level as was observed for the glycosylated protein level and the size of the GAG chain. Thus, while several of the enzymes known to synthesize CS/DS GAG chains may be involved in myocardial remodeling following AB, CHPF and CHSY-1 may be of particular importance in reverse remodeling during DB.
In the present study we found increased gene expression of the inflammatory chemokine CXCL16 after AB no longer significantly increased following relief of pressure overload. We have previously shown that the chemokines CXCL13, CXCL16, CX3CL1, and CCL5 are increased in pressure-overloaded ventricles and also induce increased expression of several SLRPs in cardiac fibroblasts (35, 36) . In the present study we extend these findings by showing that CXCL16, but not any of the other tested chemokines, increased the expression of the CS/DS-synthesizing enzyme CHPF. Thus the decreased levels of CXCL16 after DB might contribute to the decreasing molecular size and total protein levels of decorin. CHPF has just recently been discovered and shown to play a role in CS/DS GAG synthesis (20) . It is shown that CHPF when expressed alone does not show synthesizing activity, but when it is expressed with other enzymes it is capable of mediating chain synthesis (16) . One possibility is that glycosylation of decorin and elongation of the GAG chain of decorin may occur due to the combined effect of CXCL16 and TGF-␤, which increased the expression of CHSY-1 and-3. Decorin and CS GAG-synthesizing enzymes have previously been shown to bind to TGF-␤ and thus inhibit its fibrotic effects (2, 18) . Interestingly, we found increased expression of CHSY-1, -3 and DS epimerase following stimulation with TGF-␤, which may be due to a negative feedback mechanism occurring between these enzymes and TGF-␤.
In the present study, we found that N-glycosylated lumican core protein was increased by sevenfold in the LV after AB, which was reversed after DB. A possible role for N-glycosylated lumican in cardiac remodeling was supported by the positive correlations between N-glycosylated lumican with genes associated with myocardial fibrosis, cardiomyocyte hypertrophy, LV weight, and lung weight. Binding of the core protein of lumican to collagen fibrils, regulating fibril diameter and lateral fusion, seems to be crucial for the architecture and stability of the collagen network (38) . It is tempting to hypothesize that an increase in the protein level of N-glycosylated lumican core protein is important for proper collagen architecture also during pressure overload in the heart, a process that is reversed after DB. Interestingly, we found that mRNA expression of only two of seven KS GAG-synthesizing enzymes was increased after AB. On the protein level, we found no significant alterations of these enzymes, although B3GNT-7 was decreased after DB. This supports that there was only a small increase in the protein level of lumican with KS GAG chains in the LV during pressure overload.
The decreasing protein levels of glycosylated decorin and N-glycosylated lumican following relief of pressure overload might be due to decreased production as a consequence of a decline in mediators stimulating their synthesis such as CXCL16, but could also reflect increased degradation. Indeed, degradation and cleavage of decorin and lumican have been shown to be induced by certain matrix metalloproteinases (MMPs) (23, 37) , and previous studies have shown increased levels of MMPs in the clinical setting of reverse cardiac remodeling (4, 24) .
Our findings in the present study suggest a role for glycosylated decorin and N-glycosylated lumican core protein in myocardial remodeling and reverse remodeling following AB and DB, respectively. Moreover, several CS/DS GAG chainsynthesizing enzymes are upregulated in the pressure-overloaded LV corresponding well to the increased levels of glycosylated decorin, and notably two of these enzymes (i.e., CHPF and CHSY-1) decrease during DB, suggesting a role for these enzymes during reverse remodeling. Although further studies are required to precisely define the role of SLRPs in cardiac remodeling and reverse remodeling, our findings may suggest that certain SLRPs and related enzymes could represent novel targets for therapy in these processes. n ϭ 4 -6) . All values are presented relative to unstimulated (control) and are normalized to GAPDH. *P Ͻ 0.05.
